Skip to main content

Red wine may protect against breast cancer for some women at increased risk


As we have discussed here before, the question of alcohol consumption and breast cancer is a volatile one, but a new study helps to shed some light on the subject. It becomes especially difficult for a subset of women with a genetic trait that places them at increased risk. Two genes, called BRCA1 and BRCA2, are mutations of genes that normally code for tumor suppression. When one of these mutations is present, the chances of developing breast cancer are substantially increased, and it is now routine to test for them when there is a family history of breast cancer. And given the consensus that alcohol consumption further increases the odds of developing breast cancer, it might make sense that the BRCA gene and drinking would be an especially dangerous mix. But when it comes to red wine, the story takes a different turn.


This new study, from the University of Ottawa in Montreal, looked at a large population of women with breast cancer, and tested them for BRCA. Additionally, drinking habits were determined by questionnaire. Interestingly, women with BRCA1 who were primarily red wine drinkers had about half of the expected incidence, and alcohol had no correlation at all. For BRCA2 positive women, alcohol was independently associated with breast cancer but red wine had no relationship.

So for BRCA-positive women, the effect of red wine really depends on which type; BRCA2 women should probably seriously consider avoiding alcohol of any type (unless they choose to have prophylactic mastectomy with reconstruction) while BRCA1 women might seriously consider cultivating a taste for cabernet. It’s a confused message, since the original purpose of the study was to clarify the magnitude of alcohol as a risk factor for BRCA-positive women, but the unexpected benefit for wine drinkers adds a layer of complexity. It’s not the first crack in the consensus about wine and breast cancer though, since populations where wine is regularly consumed there is a much lower incidence of breast cancer. The difficulty is statistically teasing out the true wine drinkers from the mixed and erratic drinking patterns in most populations.

Comments

  1. On the questionnaire for alcohol consumption, only 10 BRCA1 women were measured. Do you really think that's a large enough sample to project the benefit of red wine for BRCA1 carriers?

    ReplyDelete

Post a Comment

Popular posts from this blog

Versatile resveratrol: the ultimate skin care ingredient?

  Part 1 Recently I was honored to join Professors David Sinclair of Harvard and Joseph Vercauteren of the University of Montpelleir at an anti-aging symposium at the invitation of Mathilde Thomas of Caudalie in Paris. Caudalie has been using wine extracts (and specifically resveratrol) in their products for more than 15 years, after Vercauteren identified it in wine grape vines. Sinclair has become well known for his work identifying the role of sirtuin (SIRT) genes in anti-aging, and resveratrol as a natural sirtuin activator. While much remains to be proven, it is fair to say that science is finally beginning to have an impact on skin care. With an increasing understanding of what causes aging in skin cells and how botanical antioxidants such as resveratrol work at a molecular level, there is no excuse to use anti-aging skin care products that don’t multitask. Before delving into the potential benefits of resveratrol in skin care, it may help to review ho...

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...